Conference Coverage
about 6 hours ago
ESCRS 2026: Ultra-widefield imaging in paediatric eye careTrending on the Eye Care Network
1
OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
2
RCA releases first State of Retina Care report
3
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
4
Addressing geographic variation in dry eye disease care requires patient-centric approaches
5
Geographic atrophy featured across EURETINA 2026 scientific programme
Latest News
Sep 21, 2026 | News
Aaberg: predictors of high response to Encelto in MacTel type 2
Geographic atrophy featured across EURETINA 2026 scientific programme
Sep 21, 2026
Addressing geographic variation in dry eye disease care requires patient-centric approaches
Sep 21, 2026
Vienna calling: Inside the 26th EURETINA Congress
Sep 19, 2026
The association between atrial fibrillation and the eye
Sep 16, 2026
Advertisement
Shorts
1:09
ESCRS 2026: Fitting light therapy into the cataract surgery workflow
8 hours ago
0:56
ESCRS 2026: Why retinal measurements can be wrong
4 days ago
0:39
ESCRS 2026: What makes a good candidate for aceclidine drops?
6 days ago
1:03
Intra-Operative OCT During Glaucoma Surgeries
8 days ago
0:50
Building a low-level light therapy workflow
9 days ago
1:08
AI's growing role in ophthalmology screening and outcomes analysis
10 days ago
0:40
Dr. Radhika Rampat: AI in practice today
11 days ago
0:33
Fast ocular surface stabilization with dry eye lubricating drop: Piotr Wozniak, MD
a month ago
0:36
Redefining surgical success as "20/happy"
2 months ago
0:58
How ectoine's molecular shield protects the ocular surface
2 months ago
Digital Edition
Ophthalmology Times Europe
Waste, cost and carbon are converging to reshape how cataract centres choose instruments.
Ophthalmology Times Europe
Why AI-driven functional imaging could change how clinicians assess and treat retinal disease
Ophthalmology Times Europe
David E. I. Pyott, CBE, MD(Hon), MBA, MA, discusses expanding subspecialty training and internationally recognized credentials in underserved regions.
Ophthalmology Times Europe
Charlie Zhang, MD, reflects on the rising incidence, diagnostic challenges and multidisciplinary management of immune checkpoint inhibitor–associated uveitis
Ophthalmology Times Europe
AI models predicting retinal function from OCT could transform geographic atrophy assessment in clinical care and trials
Ophthalmology Times Europe
Two cases highlight the diagnostic challenges of Demodex blepharitis and underscore the unmet need for approved targeted therapies in the United Kingdom.
Ophthalmology Times Europe
Utilize oral agents, diet and glucose monitoring systems when
acting to preserve vision
Ophthalmology Times Europe
New pathways are reshaping the management of retinal disease
Ophthalmology Times Europe
Immediate flushing of the eye can significantly reduce long-term damage after chemical exposure
Ophthalmology Times Europe
After accounting for key factors like eye length, researchers found no meaningful differences in corneal biomechanics between primary open-angle and primary angle-closure glaucoma.
Podcasts
Continuing Medical Education
Advertisement
All News
Advertisement
Bausch + Lomb's SeeLyra femtosecond laser platform, featuring live OCT imaging, has received CE mark approval for cataract, LASIK, and corneal procedures in Europe.
In patients reporting chronic ocular pain, dry eye may not be the entire diagnosis.
Polish investigators showed that various modalities can quantify ocular changes in attention deficit/hyperactivity disorder.
Mingo-Botín, MD, PhD, discusses ESCRS 2026 data on an EDOF IOL in post-LASIK eyes vs non-LASIK controls.
The 44th Congress of the ESCRS kicked off at ExCeL London with iNovation Day and the Opening Ceremony, setting the stage for a five-day programme.
Handheld IC1000 pairs rebound tonometry with camera-guided alignment
Ahead of the 44th ESCRS Congress in London, a look at the presbyopia-correcting IOL, glaucoma and dry eye disease research on this year's scientific programme.
New research covers a 3D OCT foundation model, an OCTA biomarker review and offline smartphone screening for three retinal diseases.
A gamified program may speed the brain’s adjustment, new data suggest.
When to retest for inherited retinal dystrophies
Published: | Updated:
João Pedro Marques, MD, PhD, on how systematic reanalysis moved a cohort's solved rate from 59.4% to 70.1% and what it means for gene therapy eligibility
Advertisement
A systematic review of 21 studies found OCTA detects early diabetic retinopathy—reduced vessel density being the most consistent biomarker—but heterogeneous, unstandardized evidence isn't sufficient for routine clinical screening yet.
Japan designated gildeuretinol an orphan drug for Stargardt disease as the oral therapy enters phase 3 evaluation in the NORTHSTAR trial.
A preclinical study of the effects of aflibercept (Eylea, Regeneron Pharmaceuticals) and faricimab (Vabysmo-svoa, Genentech) showed that the two treatments were equal in their ability to maintain or restore the retinal endothelial barrier function and resultant visual integrity. Investigators attributed this result mainly to inhibiting vascular endothelial growth factor A165 from binding to its receptor.
Matias Iglicki, MD, PhD, on patient selection, technical pitfalls and why symmetry decides outcomes in flanged vs sutured fixation
Researchers in the UK have developed a new treatment approach for aniridia-related keratopathy (ARK), a rare genetic ocular disease, namely, a collagen scaffold that delivers limbal epithelial stem cells and stromal stem cells to the area affected by ARK. The treatment resulted in improved ocular surface scores and visual acuities.
Advertisement
Advertisement